rs143817729
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001378609.3(OTOGL):c.4906G>A(p.Glu1636Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00204 in 1,611,698 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0013 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 5 hom. )
Consequence
OTOGL
NM_001378609.3 missense
NM_001378609.3 missense
Scores
3
9
Clinical Significance
Conservation
PhyloP100: 4.22
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.00897333).
BP6
?
Variant 12-80339120-G-A is Benign according to our data. Variant chr12-80339120-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 227824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
?
High Homozygotes in GnomAd at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.4906G>A | p.Glu1636Lys | missense_variant | 43/59 | ENST00000547103.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.4906G>A | p.Glu1636Lys | missense_variant | 43/59 | 5 | NM_001378609.3 | P1 | |
OTOGL | ENST00000646859.1 | c.4771G>A | p.Glu1591Lys | missense_variant | 47/63 | ||||
OTOGL | ENST00000298820.7 | c.208G>A | p.Glu70Lys | missense_variant | 4/18 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.00136 AC: 206AN: 151760Hom.: 3 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
206
AN:
151760
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00165 AC: 407AN: 246378Hom.: 2 AF XY: 0.00170 AC XY: 227AN XY: 133900
GnomAD3 exomes
AF:
AC:
407
AN:
246378
Hom.:
AF XY:
AC XY:
227
AN XY:
133900
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00211 AC: 3075AN: 1459820Hom.: 5 Cov.: 32 AF XY: 0.00207 AC XY: 1506AN XY: 726298
GnomAD4 exome
AF:
AC:
3075
AN:
1459820
Hom.:
Cov.:
32
AF XY:
AC XY:
1506
AN XY:
726298
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00135 AC: 205AN: 151878Hom.: 3 Cov.: 32 AF XY: 0.00127 AC XY: 94AN XY: 74250
GnomAD4 genome
?
AF:
AC:
205
AN:
151878
Hom.:
Cov.:
32
AF XY:
AC XY:
94
AN XY:
74250
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
8
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
11
ExAC
?
AF:
AC:
200
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | OTOGL: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 05, 2022 | See Variant Classification Assertion Criteria. - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 10, 2023 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 17, 2015 | p.Glu1627Lys in exon 42 of OTOGL: This variant is not expected to have clinical significance because it has been identified in 0.3% (39/11552) of Latino chromos omes and 0.23% (155/66672) European chromosomes by the Exome Aggregation Consort ium (ExAC, http://exac.broadinstitute.org; dbSNP rs143817729). - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N
PrimateAI
Benign
T
Vest4
0.22
MVP
0.38
MPC
0.027
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at